Literature DB >> 18848864

Neuro-immune crosstalk in CNS diseases.

M Kerschensteiner1, E Meinl, R Hohlfeld.   

Abstract

Immune cells infiltrate the CNS in many neurological diseases with a primary or secondary inflammatory component. In the CNS, immune cells employ shared mediators to promote crosstalk with neuronal cells. The net effect of this neuro-immune crosstalk critically depends on the context of the interaction. It has long been established that inflammatory reactions in the CNS can cause or augment tissue injury in many experimental paradigms. However emerging evidence suggests that in other paradigms inflammatory cells can contribute to neuroprotection and repair. This dual role of CNS inflammation is also reflected on the molecular level as it is becoming increasingly clear that immune cells can release both neurodestructive and neuroprotective molecules in CNS lesions. It is thus the balance between destructive and protective factors that ultimately determines the net result of the neuro-immune interaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18848864     DOI: 10.1016/j.neuroscience.2008.09.009

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  60 in total

1.  Expression and distribution of immunoglobulin G and its receptors in an immune privileged site: the eye.

Authors:  Na Niu; Jie Zhang; Yingui Sun; Shuna Wang; Yonghong Sun; Christine Korteweg; Weiwei Gao; Jiang Gu
Journal:  Cell Mol Life Sci       Date:  2011-07       Impact factor: 9.261

2.  Relationship between inflammatory mediators, Aβ levels and ApoE genotype in Alzheimer disease.

Authors:  M Reale; M A Kamal; L Velluto; D Gambi; M Di Nicola; N H Greig
Journal:  Curr Alzheimer Res       Date:  2012-05       Impact factor: 3.498

Review 3.  T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?

Authors:  Stanley H Appel; David R Beers; Jenny S Henkel
Journal:  Trends Immunol       Date:  2009-10-31       Impact factor: 16.687

4.  Pediatric reference ranges for proinflammatory and anti-inflammatory cytokines in cerebrospinal fluid and serum by multiplexed immunoassay.

Authors:  Michael R Pranzatelli; Elizabeth D Tate; Nathan R McGee; Jerry A Colliver
Journal:  J Interferon Cytokine Res       Date:  2013-05-09       Impact factor: 2.607

Review 5.  The benefits of neuroinflammation for the repair of the injured central nervous system.

Authors:  Heather Y F Yong; Khalil S Rawji; Samira Ghorbani; Mengzhou Xue; V Wee Yong
Journal:  Cell Mol Immunol       Date:  2019-03-15       Impact factor: 11.530

6.  Gut-brain chemokine changes in portal hypertensive rats.

Authors:  Joaquin Merino; Maria-Angeles Aller; Sandra Rubio; Natalia Arias; Maria-Paz Nava; Maria Loscertales; Jaime Arias; Jorge-Luis Arias
Journal:  Dig Dis Sci       Date:  2011-02-24       Impact factor: 3.199

7.  Oxidative stress and immune aberrancies in attention-deficit/hyperactivity disorder (ADHD): a case-control comparison.

Authors:  Annelies A J Verlaet; Annelies Breynaert; Berten Ceulemans; Tess De Bruyne; Erik Fransen; Luc Pieters; Huub F J Savelkoul; Nina Hermans
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-10-22       Impact factor: 4.785

Review 8.  Fetal inflammatory response and brain injury in the preterm newborn.

Authors:  Shadi Malaeb; Olaf Dammann
Journal:  J Child Neurol       Date:  2009-07-15       Impact factor: 1.987

9.  Caffeine enhances astroglia and microglia reactivity induced by 3,4-methylenedioxymethamphetamine ('ecstasy') in mouse brain.

Authors:  Amit Khairnar; Antonio Plumitallo; Lucia Frau; Nicoletta Schintu; Micaela Morelli
Journal:  Neurotox Res       Date:  2009-10-31       Impact factor: 3.911

Review 10.  Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation.

Authors:  Scott A Friedle; Marjorie A Curet; Jyoti J Watters
Journal:  Recent Pat CNS Drug Discov       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.